Artificial intelligence has entered a new phase in health care. Utah has authorized a pioneering pilot program enabling an AI system to issue initial medication prescriptions without a doctor’s visit. Nolla Health launched this initiative focusing on acne treatment after collaborating with the Utah Office of Artificial Intelligence Policy. The program commenced on October 5 for Utah residents aged 18 and older through the Nolla Derm app.
This pilot follows a controversial AI-prescribing trial. In April, the Utah Medical Licensing Board urged officials to halt a program by Doctronic that used AI for prescription renewals. They stressed that prescriptions require clinical oversight due to safety concerns like side effects and drug interactions.
What Is Nolla Health?
Nolla Health is a health tech firm utilizing AI to enhance health care access. CEO Luis Wenus advocates for affordable, high-quality care for all. The company’s app, focused on dermatology, has been downloaded by over 175,000 users across 44 states.
Why Automate Acne Medication?
Acne treatment is standardized, making it a suitable candidate for AI-assisted prescribing. Nolla highlights that while over 100,000 Utah residents have acne, only 10 percent consult a dermatologist. Average wait times for appointments extend to 61 days, prompting the need for streamlined care.
Critics argue that AI should not replace doctors in prescribing. Regulators emphasize that health conditions and medication interactions require human judgment.
How the AI Prescription System Works
The Nolla Derm app requires users to verify their identity, consent, fill a medical questionnaire, and submit a facial scan. The AI processes this information to propose a treatment plan within 10 to 15 minutes. Qualifying patients receive an initial prescription, which can be filled at pharmacies or delivered.
This AI system functions within a predetermined treatment scope, unlike open-ended chatbots. Patients with complex issues are referred to physicians.
To ensure safety, the program mandates oversight. The first 100 prescriptions require approval from two licensed doctors. Ongoing evaluation aims for physician agreement with the AI’s recommendations and minimal adverse events.
Are AI Prescriptions a Sign of Things To Come?
This pilot draws attention for issuing initial prescriptions, advancing beyond refills. Utah was the first state to permit AI to renew prescriptions for chronic conditions. Nolla Health’s program tests if AI can reliably undertake roles traditionally filled by doctors.
While limited to Utah, adults, and specific acne treatments, this initiative may set a precedent. Success could lead to similar programs for other low-risk conditions and support for addressing physician shortages and high demand.

Understanding the Rise in Stroke Risk Among Young Americans
A Headache Leads to a Life-Threatening Discovery for Julie Nashawaty
Advocates Step In as Official Channels Struggle with Family Homelessness
From Birth to Bravery: A Story of Overcoming Clubfoot
Exploring Beverages for a Longer Life in Blue Zones
Growing Support for Government-Run Health Insurance in the United States